John Tavis, PhD

Research Interest

I study hepatitis B virus replication and hepatitis C virus genetics. HBV and HCV together cause 75% of primary liver cancer world-wide. My work with HBV ranges from basic biology to drug discovery. We are currently developing novel anti-HBV ribonuclease H inhibitors as early drug candidates. Our work with HCV extends from basic genetics to development of algorithms predictive of response to therapy.

Education

• 1990: PhD, molecular and cell biology, Pennsylvania State University, State College, Penn.

Training

• 1990 - 1991: Post-doctoral scholar, Pennsylvania State University
• 1991 - 1994: Post-doctoral scholar, University of California, San Francisco

Journal Articles

Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.